Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Full House Resorts NASDAQFLL Quarterly Earnings Preview and Historical Performance

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
financial-data
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Full House Resorts (NASDAQ:FLL) is gearing up to announce its quarterly earnings on March 5, 2024. Analysts are projecting an EPS of $-0.14 for the company, and investors are hopeful for a positive outlook for the next quarter, as guidance tends to have a greater impact on stock prices than earnings surprises.

In the previous quarter, Full House Resorts exceeded expectations by $0.21, resulting in an impressive 18.67% increase in share price the following day. Here is a look back at the company’s historical earnings performance and the corresponding price fluctuations:
– Q3 2023: EPS Estimate -0.08, EPS Actual 0.13, Price Change 19.0%
– Q2 2023: EPS Estimate 0.05, EPS Actual -0.16, Price Change -17.0%
– Q1 2023: EPS Estimate -0.14, EPS Actual -0.33, Price Change 9.0%
– Q4 2022: EPS Estimate -0.11, EPS Actual -0.07, Price Change -11.0%

With Full House Resorts’ shares trading at $5.35 as of March 1, reflecting a 47.63% decline over the past year, long-term investors may be feeling cautious leading up to this earnings announcement.

Stay updated on Full House Resorts’ earnings by checking out their calendar on various platforms.

FLL Stock Declines by 4.11% on March 4, 2024: What Investors Need to Know

On March 4, 2024, FLL stock experienced a decline in its performance, with the price dropping by 4.11% or $0.22 since the market last closed. The stock opened at $5.46, which was $0.11 higher than its previous close. This downward trend is reflected in the fact that FLL is currently trading near the bottom of its 52-week range and below its 200-day simple moving average.

Investors may be concerned about the recent price momentum of FLL, as the stock continues to show signs of weakness. The decline in share price could be attributed to a variety of factors, such as market conditions, company performance, or industry trends.

It is important for investors to closely monitor the performance of FLL and consider the reasons behind the recent price drop. They may want to analyze the company’s financial health, competitive positioning, and growth prospects to determine whether the current stock price presents a buying opportunity or if it is a sign to stay cautious.

FLL Stock Performance Analysis: Revenue and Net Income Show Mixed Results

On March 4, 2024, FLL stock showed mixed performances based on the financial data provided by CNN Money. The total revenue for the company was $163.28 million over the past year, which was a decrease of 9.37% compared to the previous year. However, the total revenue for the last quarter was $71.54 million, showing an increase of 20.48% since the previous quarter.

The net income for FLL was -$14.80 million over the past year, indicating a significant decrease of 226.47% compared to the previous year. However, the net income for the last quarter was $4.59 million, showing a substantial increase of 182.02% since the previous quarter.

Earnings per share (EPS) for FLL were -$0.43 over the past year, which was a decrease of 228.63% compared to the previous year. However, the EPS for the last quarter was $0.13, showing an increase of 177.14% since the previous quarter.

Tags: FLL
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Financial literacy and school

MGE Energy Surges as it Joins SP SmallCap 600 Index

Technology Data analytics stock Trading (1)

Whales Show Strong Confidence in Palantir Technologies through Options Activity

Biotechnology Markets and money

Jim Lebenthals Surprising Decision Selling Thermo Fisher Scientific

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com